Summary
This report presents a forensic review of an article published in Antioxidants (MDPI) in 2025 concerning short-chain fatty acids in an MPTP mouse model of Parkinson's disease. The review concludes with a strong adverse verdict (实锤 / substantiated concerns) based on multiple internal contradictions. Key issues include: (1) an anatomical inconsistency where the methods describe striatal tissue for biochemical assays, while the results and Figure 5E report substantia nigra glutamate measurements; (2) an arithmetic impossibility in animal allocation, since n=12 per group cannot yield 15 separate tissue samples across immunohistochemistry, Western blot, biochemistry, and ELISA; (3) implausibly extreme statistical significance (p<0.0001) in a Western blot with only n=3 per group, suggesting suspiciously low variance; (4) confusion between plasma and serum in cytokine analysis; and (5) a rapid 22-day submission-to-acceptance timeline typical of high-volume MDPI journals. Limitations: this analysis is based on the published PDF only; original data and lab records were not examined, and findings should be treated as indicators warranting institutional investigation.
Verdict
🔴
Substantiated concerns — Multiple internal contradictions and statistical anomalies are identified that are difficult to reconcile with sound experimental practice. Formal institutional investigation is warranted.
Key findings
- Anatomical inconsistency between striatum and substantia nigra — Methods section specifies striatal tissue, while results and Figure 5E report substantia nigra glutamate measurements.
- Mathematically impossible animal allocation — n=12 per group cannot supply 15 distinct samples (3 TH + 3 GFAP + 3 WB + 6 biochemistry + 6 ELISA), and the same brain cannot be split between fixed immunohistochemistry and fresh biochemical assays without explicit procedural description.
- Implausibly high statistical significance at n=3 — One-way ANOVA with df=2 yielding p<0.0001 requires near-zero within-group variance, a pattern suggestive of data fabrication.
- Plasma vs. serum terminology confusion — Methods and figure legend specify plasma ELISA; results text reads "serum."
- Suspiciously fast publication timeline — Submitted 2025-11-02, accepted 2025-11-24 (22 days), published 2025-11-27.
Evidence highlights
- Finding 1 location: §2.6 states "Striatal tissues from 6 mice per group were used for these biochemical assays." §3.5 and Figure 5E report "glutamate concentration in the substantia nigra."
- Finding 2 arithmetic: 3 + 3 + 3 + 6 + 6 = 15 samples required per group versus declared n=12 per group.
- Finding 3 statistic: Figure 7 SOD2 Western blot, n=3 per group, reported p<0.0001; raw data points and individual error bars not displayed (mean±SEM only).
- Finding 4 wording: §3.4 reads "Plasma cytokine analysis revealed that MPTP treatment significantly elevated serum levels of inflammatory markers, including IL-6..."
- Finding 5 timeline: Received 2025-11-02; revised 2025-11-22; accepted 2025-11-24; published 2025-11-27.
- DOI: 10.3390/antiox14121429
Notes
- This review is based solely on the published PDF; raw data, uncropped blots, and laboratory notebooks were not examined.
- The 22-day timeline, while unusual, is consistent with MDPI's standard peer-review workflow and alone does not constitute misconduct.
- Definitive determination of academic fraud requires institutional investigation with access to original records.
- Report generated with AI assistance; false positives and negatives are possible.
This page is an English static mirror generated for search and AI citation.
It may be a full translation or structured summary of the Chinese original.
Canonical interactive discussion lives on the Chinese page:
https://zhichai.net/report/geng_geng_6a350fcbbada83.56729795